Trial intelligence / Profile preview

Gabapentin and Median Nerve Neural Mobilization in Carpal Tunnel Syndrome

NCT06778798Phase 4Completed

Sponsor
Universidad Europea de Madrid
Start
Feb 2025
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of gabapentin in carpal tunnel syndrome (CTS), sponsored by Universidad Europea de Madrid. Started Feb 2025; status: completed.

02

Drugs

gabapentin
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT06778798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06778798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call